Linola

Urea, the active ingredient in Linola, is a keratolytic presented as a topical preparation for skin application. It helps hydrate the skin and promotes the shedding of excess keratin, making it useful for dry, scaly or hyperkeratotic conditions in adults and children. GNH USA supplies Linola as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linola (Urea) is applied topically to manage disorders characterized by excessive keratin buildup and skin dryness.

Dry skin: restores moisture and softens scaling. Ichthyosis: reduces hyperkeratinization and improves skin texture. Psoriasis: alleviates plaque scaling and promotes desquamation. Hyperkeratosis: softens thickened skin and facilitates shedding.

Common Side Effects: - Mild skin irritation or itching at the application site. - Transient burning or stinging sensation. - Redness or erythema. - Dryness or peeling of treated skin.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling and rash. - Severe skin ulceration or bullous reactions. - Systemic toxicity (rare) with signs such as nausea or headache.

Before using Linola, consider the following precautions: - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown; consult a healthcare professional. - Skin integrity: do not apply to broken, infected, or inflamed skin. - Concurrent keratolytics: monitor for increased irritation. - Allergy: discontinue if hypersensitivity develops. - Store at ambient temperature: keep container tightly closed, protect from moisture and direct sunlight.

Linola may interact with other topical agents.

Major Interactions (Avoid): - Use with strong topical steroids may increase irritation. - Combination with other keratolytic agents (e.g., salicylic acid) can cause excessive peeling. - Large‑area application with systemic diuretics may increase rare systemic absorption.

Moderate Interactions (Monitor Closely): - Co‑application with moisturizers may enhance efficacy. - Use under occlusive dressings may increase absorption. - Concurrent topical antibiotics may mask infection signs.